Led by CEO Harry Rowland, VahatiCor is developing the A-Flux coronary sinus reducer implant for coronary microvascular dysfunction.
Expansion plans at Areva's remote uranium mining site in Saskatchewan, Canada, calls for an upgrade of the facility's distributed control system (DCS) to one with integrated, intrinsically safe I/O.